Publication | Closed Access

Phospho-ERK is a biomarker of response to a synthetic lethal drug combination of sorafenib and MEK inhibition in liver cancer

Tumor BiologyOncologyOncogenic AgentMedicineReceptor Tyrosine KinaseMek InhibitionLiver CancerAnti-cancer AgentPharmacologyRadiation OncologyCancer ResearchDrug Discovery